Search Result "Interferon Signature"
Type I Interferon as a Target of Treatment in SLE
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 6 Issue: 4 Year: 2006 Page: 323-330
Author(s): P. Y. Lee, W. H. Reeves
Therapeutic Approaches for COVID-19 Based on the Interferon-Mediated Immune Responses
Journal: Current Signal Transduction Therapy
Volume: 16 Issue: 3 Year: 2021 Page: 269-279
Author(s): Pouria Mosaddeghi,Farbod Shahabinezhad,Zahra Dehghani,Mitra Farahmandnejad,Mohammad Javad Taghipour,Mohsen Moghadami,Navid Nezafat,Seyed Masoom Masoompour,Manica Negahdaripour
Novel Gene Signature based on Immune Cell InfiltrationLandscape Predicts Prognosis in Lung Adenocarcinoma Patients
Journal: Current Medicinal Chemistry
Volume: 31 Issue: 38 Year: 2024 Page: 6319-6335
Author(s):
Can Systems Biology Understand Pathway Activation? Gene Expression Signatures as Surrogate Markers for Understanding the Complexity of Pathway Activation
Journal: Current Genomics
Volume: 9 Issue: 5 Year: 2008 Page: 349-360
Author(s): Hiraku Itadani, Shinji Mizuarai, Hidehito Kotani
Roles of Interferon Induced Protein with Tetratricopeptide Repeats (IFIT) Family in Cancer
Journal: Current Medicinal Chemistry
Volume: 28 Issue: 25 Year: 2021 Page: 5034-5047
Author(s): Xing Fei Tan,Qifan Chen,San Hue Hua,George Wai Yip
Primary Sjogrenâs Syndrome and the Type I Interferon System
Journal: Current Pharmaceutical Biotechnology
Volume: 13 Issue: 10 Year: 2012 Page: 2054-2062
Author(s): Gunnel Nordmark,Maija-Leena Eloranta,Lars Ronnblom
Role of Interferons in Chronic Hepatitis C Infection
Journal: Current Drug Targets
Volume: 18 Issue: 7 Year: 2017 Page: 844-850
Author(s): Carolina Scagnolari,Katia Monteleone,Giulia Cacciotti,Guido Antonelli
Development of a Combined Oxidative Stress and Endoplasmic ReticulumStress-Related Prognostic Signature for Hepatocellular Carcinoma
Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 27 Issue: 19 Year: 2024 Page: 2850-2860
Author(s):
The Contribution of Transcriptomics to Biomarker Development in Systemic Vasculitis and SLE
Journal: Current Pharmaceutical Design
Volume: 21 Issue: 1 Year: 2015 Page: 2225-2235
Author(s): Shaun M. Flint, Eoin F. McKinney, Paul A. Lyons, Kenneth G.C. Smith
Interferon-beta Inhibits Th17 Cell Differentiation in Patients with Multiple Sclerosis
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 10 Issue: 2 Year: 2010 Page: 161-167
Author(s): Vinod S. Ramgolam, Silva Markovic-Plese